Full Press Release Details
dupixent dupilumab approved in the u s as the first ever biologic medicine for patients with copd.
REGN
dupixent dupilumab approved in the u s as the first ever biologic medicine for patients with copd
Key Takeaway: dupixent dupilumab approved in the u s as the first ever biologic medicine for patients with copd